Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC Goes For $750 Mil. As Numico Exits Dietary Supplement Industry

This article was originally published in The Tan Sheet

Executive Summary

GNC will sell for about half of its annual sales under an agreement between parent Royal Numico and New York-based holding company Apollo Management

You may also be interested in...



Danone Enters Infant Formula Market With Numico Acquisition

Groupe Danone's $16.8 billion acquisition of Royal Numico expands the firm's healthy nutrition focus with entry into the infant formula market and a stronger position in clinical nutrition, the company says July 10

Danone Enters Infant Formula Market With Numico Acquisition

Groupe Danone's $16.8 billion acquisition of Royal Numico expands the firm's healthy nutrition focus with entry into the infant formula market and a stronger position in clinical nutrition, the company says July 10

Danone Enters Infant Formula Market With Numico Acquisition

Groupe Danone's $16.8 billion acquisition of Royal Numico expands the firm's healthy nutrition focus with entry into the infant formula market and a stronger position in clinical nutrition, the company says July 10

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS096060

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel